Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Lundh

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Journal of Hematology|June 29, 2020
Next-generation CAR T cells to overcome current drawbacksStefan Lundh, Sayantan Maji, J Joseph Melenhorst
Clinical and Experimental Medicine|April 26, 2020
Clinical practice: chimeric antigen receptor (CAR) T cells: a major breakthrough in the battle against cancerStefan Lundh, In-Young Jung, Alexander Dimitri, et al.
Science Advances|July 19, 2023
TOX2 coordinates with TET2 to positively regulate central memory differentiation in human CAR T cellsSierra M Collins, Katherine A Alexander, Stefan Lundh, et al.
Cancer Research Communications|March 16, 2023
Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLLMcKensie A Collins, In-Young Jung, Ziran Zhao, et al.
Journal for Immunotherapy of Cancer|May 19, 2021
Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cellsZhiliang Bai, Stefan Lundh, Dongjoo Kim, et al.
Science Advances|June 8, 2022
Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALLZhiliang Bai, Steven Woodhouse, Ziran Zhao, et al.
Nature|December 8, 2022
Author Correction: Decade-long leukaemia remissions with persistence of CD4<sup>+</sup> CAR T cellsJ Joseph Melenhorst, Gregory M Chen, Meng Wang, et al.
Nature|February 3, 2022
Decade-long leukaemia remissions with persistence of CD4<sup>+</sup> CAR T cellsJ Joseph Melenhorst, Gregory M Chen, Meng Wang, et al.
Nature Medicine|February 6, 2021
Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemiaJoseph A Fraietta, Simon F Lacey, Elena J Orlando, et al.
Nature Medicine|May 2, 2018
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemiaJoseph A Fraietta, Simon F Lacey, Elena J Orlando, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Hematology|June 29, 2020
Next-generation CAR T cells to overcome current drawbacksStefan Lundh, Sayantan Maji, J Joseph Melenhorst
Clinical and Experimental Medicine|April 26, 2020
Clinical practice: chimeric antigen receptor (CAR) T cells: a major breakthrough in the battle against cancerStefan Lundh, In-Young Jung, Alexander Dimitri, et al.
Science Advances|July 19, 2023
TOX2 coordinates with TET2 to positively regulate central memory differentiation in human CAR T cellsSierra M Collins, Katherine A Alexander, Stefan Lundh, et al.
Cancer Research Communications|March 16, 2023
Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLLMcKensie A Collins, In-Young Jung, Ziran Zhao, et al.
Journal for Immunotherapy of Cancer|May 19, 2021
Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cellsZhiliang Bai, Stefan Lundh, Dongjoo Kim, et al.
Science Advances|June 8, 2022
Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALLZhiliang Bai, Steven Woodhouse, Ziran Zhao, et al.
Nature|December 8, 2022
Author Correction: Decade-long leukaemia remissions with persistence of CD4<sup>+</sup> CAR T cellsJ Joseph Melenhorst, Gregory M Chen, Meng Wang, et al.
Nature|February 3, 2022
Decade-long leukaemia remissions with persistence of CD4<sup>+</sup> CAR T cellsJ Joseph Melenhorst, Gregory M Chen, Meng Wang, et al.
Nature Medicine|February 6, 2021
Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemiaJoseph A Fraietta, Simon F Lacey, Elena J Orlando, et al.
Nature Medicine|May 2, 2018
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemiaJoseph A Fraietta, Simon F Lacey, Elena J Orlando, et al.
Pageof 2